Hookipa Pharma Company
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Funding Status:
IPO
Industry:
Viral Vectors
Estimated Revenue:
$1M to $10M
Headquarters:
Vienna, Wien, Austria
Total Funding:
224284354
Last Funding Date:
2022-03-02
Last Funding Type:
Post-IPO Equity
Employee Number:
51-100
Investors Number:
14
Founded Date:
2011-08-07